Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_assertion type Assertion NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_head.
- NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_assertion description "[Calpain-10 (CAPN10) gene was the first candidate gene of T2D identified through genome-wide linkage and positional cloning, but few works have focused on the relationship of CAPN10 with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) in EH patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_provenance.
- NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_assertion evidence source_evidence_literature NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_provenance.
- NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_assertion SIO_000772 20406624 NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_provenance.
- NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_assertion wasDerivedFrom befree-20140225 NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_provenance.
- NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_assertion wasGeneratedBy ECO_0000203 NP651186.RAWx6tjb4ZFcP18LmNBg-_a9gZvH5NqKusILzH8S6jbGI130_provenance.